Martin Gutierrez, Wei-Sen Lam, Adam Jacob Schoenfeld, Matthew A. Gubens, Charu Aggarwal, Daniel Shao-Weng Tan, Enriqueta Felip, Joanne Wing-Yan Chiu, Jong-Seok Lee, James Chih Hsin Yang, Edward B. Garon, Giovanna Finocchiaro, Miaojun Han, Julie Kobie, John Palcza, E.J. Dettman, Lawrence Fong, Jianda Yuan, Bin Zhao, Roy S. Herbst. "Final analysis of the biomarker-directed, randomized, phase 2 KEYNOTE-495/KeyImPaCT study of pembrolizumab (P)–based combination therapy for non–small cell lung cancer (NSCLC).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.8584